Association between benign and malignant peripheral nerve sheath tumors in NF1
- 26 July 2005
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 65 (2), 205-211
- https://doi.org/10.1212/01.wnl.0000168830.79997.13
Abstract
Objective: People with neurofibromatosis type 1 (NF1) have a 10% lifetime risk of developing a malignant peripheral nerve sheath tumor (MPNST). MPNSTs are often metastatic and are a frequent cause of death among people with NF1. Clinical evidence suggests that most MPNSTs in people with NF1 develop from preexisting plexiform neurofibromas. However, it is not known whether an individual's risk of developing an MPNST is associated with the burden of benign neurofibromas. The authors conducted a study to determine whether people with NF1 who have benign neurofibromas of various kinds are at greater risk of developing MPNSTs than patients with NF1 who lack these benign tumors. Methods: Clinical information on 476 NF1 probands in the Henri Mondor Database was analyzed by logistic regression to examine associations between MPNSTs and internal plexiform, superficial plexiform, subcutaneous, and cutaneous neurofibromas. Results: Individuals with subcutaneous neurofibromas were approximately three times more likely to have internal plexiform neurofibromas or MPNSTs than individuals without subcutaneous neurofibromas. Individuals with internal plexiform neurofibromas were 20 times more likely to have MPNSTs than individuals without internal plexiform neurofibromas. When this analysis was done with both subcutaneous and internal plexiform neurofibromas as explanatory variables, only the association of MPNSTs with internal plexiform neurofibromas remained significant. Conclusions: The observation that malignant peripheral nerve sheath tumors are strongly associated with internal plexiform neurofibromas suggests that patients with neurofibromatosis type 1 with these benign tumors warrant increased surveillance for malignancy.Keywords
This publication has 28 references indexed in Scilit:
- Elevated Risk for MPNST in NF1 Microdeletion PatientsAmerican Journal of Human Genetics, 2003
- Pathogenesis of hereditary tumors: beyond the “two‐hit” hypothesisClinical Genetics, 2002
- Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutationsHuman Genetics, 2001
- Malignancy in Neurofibromatosis Type 1The Oncologist, 2000
- Malignant Peripheral Nerve Sheath Tumors of the Head and Neck: Analysis of Prognostic FactorsOtolaryngology -- Head and Neck Surgery, 2000
- Loss ofNF1 allele in schwann cells but not in fibroblasts derived from an NF1-associated neurofibromaGenes, Chromosomes and Cancer, 1999
- Confirmation of a Double-Hit Model for the NF1Gene in Benign NeurofibromasAmerican Journal of Human Genetics, 1997
- Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 geneNature Genetics, 1995
- Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosisEuropean Journal of Surgical Oncology, 1995
- National Neurofibromatosis Foundation International DatabaseAmerican Journal of Medical Genetics, 1993